GNPNAT1 and prostate carcinoma: GNPNAT1 expression has been linked with prognosis in prostate cancer; higher expression levels have been associated with a lower risk of biochemical recurrence [99], whereas lower levels are typically seen in advanced, castrate-resistant prostate cancer when compared to localised disease [100].